Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01430299 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion
A NA study of Spondylosis and Stenosis, sponsored by SeaSpine.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT01430299 is a NA study of Spondylosis and Stenosis that has completed, run by SeaSpine. The registered enrollment target is 43 participants, below the 67-participant average among 8 other Spondylosis trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01430299, a NA study of Spondylosis and Stenosis, has completed, sponsored by SeaSpine.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for posterolateral spine fusion with a retrospective comparison to a historical patient cohort.
Conditions Studied
Interventions
- DEVICE Demineralized Bone Matrix
- DEVICE rh-BMP2
Study Locations (1)
California
- University of CA-Davis, Dept. of Orthopaedics, Adult & Pediatric Spine Surgery - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01430299
The ClinicalTrials.gov registry entry for NCT01430299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 8 other Spondylosis trials with a reported enrollment target (36% lower). The listed sponsor is SeaSpine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spondylosis appearing as the primary indexed condition, and to 2 interventions - of which Demineralized Bone Matrix is the first listed.
NCT01430299 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01430299 about?
NCT01430299 is a clinical study titled "Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion". The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for posterolateral spine fusion with a retrospective comparison to a historical patient cohort.
What is the current status of trial NCT01430299?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2011-06. Estimated completion is 2016-10.
What conditions does trial NCT01430299 study?
This clinical trial studies the following conditions: Spondylosis, Stenosis, Degenerative Changes.
What interventions are being tested in trial NCT01430299?
The interventions under investigation include: Demineralized Bone Matrix (DEVICE), rh-BMP2 (DEVICE).
Who is sponsoring clinical trial NCT01430299?
This trial is sponsored by SeaSpine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01430299 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spondylosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PREventing Pain After Surgery
RECRUITING · NA
-
CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
RECRUITING · NA
-
Recording of Intraoperative Spinal Cord Stimulation and Monitoring
RECRUITING · NA
-
Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion
COMPLETED · NA
-
Perioperative ACT for Preventing CPSP: a Single-arm Non-randomized Pilot Trial
COMPLETED · NA
-
OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.